These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17137775)

  • 1. Transforming growth factor-beta: innately bipolar.
    Wahl SM
    Curr Opin Immunol; 2007 Feb; 19(1):55-62. PubMed ID: 17137775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1β and TGF-β act antagonistically in induction and differentially in propagation of human proinflammatory precursor CD4+ T cells.
    Hebel K; Rudolph M; Kosak B; Chang HD; Butzmann J; Brunner-Weinzierl MC
    J Immunol; 2011 Dec; 187(11):5627-35. PubMed ID: 22048775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-beta-exposed plasmacytoid dendritic cells participate in Th17 commitment.
    Bonnefoy F; Couturier M; Clauzon A; Rémy-Martin JP; Gaugler B; Tiberghien P; Chen W; Saas P; Perruche S
    J Immunol; 2011 Jun; 186(11):6157-64. PubMed ID: 21518970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta and Th17 responses in resistance to primary murine schistosomiasis mansoni.
    Tallima H; Salah M; Guirguis FR; El Ridi R
    Cytokine; 2009 Dec; 48(3):239-45. PubMed ID: 19717308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg.
    Horwitz DA; Zheng SG; Wang J; Gray JD
    Eur J Immunol; 2008 Apr; 38(4):912-5. PubMed ID: 18395858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta: an important mediator of immunoregulation.
    Kehrl JH
    Int J Cell Cloning; 1991 Sep; 9(5):438-50. PubMed ID: 1955735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing effects of TGF-beta 2 on the Th1 cell development of naive CD4+ T cells isolated from different mouse strains.
    Hoehn P; Goedert S; Germann T; Koelsch S; Jin S; Palm N; Ruede E; Schmitt E
    J Immunol; 1995 Oct; 155(8):3788-93. PubMed ID: 7561083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta: recent advances on its role in immune tolerance.
    Mantel PY; Schmidt-Weber CB
    Methods Mol Biol; 2011; 677():303-38. PubMed ID: 20941619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.
    McGeachy MJ; Bak-Jensen KS; Chen Y; Tato CM; Blumenschein W; McClanahan T; Cua DJ
    Nat Immunol; 2007 Dec; 8(12):1390-7. PubMed ID: 17994024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foxp3-transduced polyclonal regulatory T cells suppress NK cell functions in a TGF-beta dependent manner.
    Zhou H; Chen L; You Y; Zou L; Zou P
    Autoimmunity; 2010 Jun; 43(4):299-307. PubMed ID: 20166879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.
    Takimoto T; Wakabayashi Y; Sekiya T; Inoue N; Morita R; Ichiyama K; Takahashi R; Asakawa M; Muto G; Mori T; Hasegawa E; Saika S; Hara T; Nomura M; Yoshimura A
    J Immunol; 2010 Jul; 185(2):842-55. PubMed ID: 20548029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta and the immune response: implications for anticancer therapy.
    Wrzesinski SH; Wan YY; Flavell RA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5262-70. PubMed ID: 17875754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alveolar type II epithelial cells present antigen to CD4(+) T cells and induce Foxp3(+) regulatory T cells.
    Gereke M; Jung S; Buer J; Bruder D
    Am J Respir Crit Care Med; 2009 Mar; 179(5):344-55. PubMed ID: 19096007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental plasticity of Th17 and Treg cells.
    Lee YK; Mukasa R; Hatton RD; Weaver CT
    Curr Opin Immunol; 2009 Jun; 21(3):274-80. PubMed ID: 19524429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble type II transforming growth factor-beta receptor inhibits established murine malignant mesothelioma tumor growth by augmenting host antitumor immunity.
    Suzuki E; Kapoor V; Cheung HK; Ling LE; DeLong PA; Kaiser LR; Albelda SM
    Clin Cancer Res; 2004 Sep; 10(17):5907-18. PubMed ID: 15355924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta, a 'double agent' in the immune pathology war.
    Cua DJ; Kastelein RA
    Nat Immunol; 2006 Jun; 7(6):557-9. PubMed ID: 16715066
    [No Abstract]   [Full Text] [Related]  

  • 17. Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells.
    Huber S; Stahl FR; Schrader J; Lüth S; Presser K; Carambia A; Flavell RA; Werner S; Blessing M; Herkel J; Schramm C
    J Immunol; 2009 Apr; 182(8):4633-40. PubMed ID: 19342638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation.
    Schmidt-Weber CB; Blaser K
    Curr Opin Immunol; 2004 Dec; 16(6):709-16. PubMed ID: 15511662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells.
    Gorelik L; Flavell RA
    Nat Med; 2001 Oct; 7(10):1118-22. PubMed ID: 11590434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state.
    Tada T; Ohzeki S; Utsumi K; Takiuchi H; Muramatsu M; Li XF; Shimizu J; Fujiwara H; Hamaoka T
    J Immunol; 1991 Feb; 146(3):1077-82. PubMed ID: 1671050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.